Hyundai Bioscience Co., Ltd. (KOSDAQ:048410)

Hyundai Bioscience Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	11,577	3,657	1,812	2,732	9,189	19,215
Short-Term Investments	23,980	-	10,000	16,000	13,010	-
Cash & Short-Term Investments	35,557	3,657	11,812	18,732	22,199	19,215
Cash Growth	705.22%	-69.04%	-36.94%	-15.62%	15.53%	172.36%
Accounts Receivable	225.97	247.21	446.21	1,277	7,628	11,035
Other Receivables	96.43	85.09	19.54	50.97	55.15	2,414
Receivables	322.4	332.3	465.75	1,671	8,825	17,250
Inventory	1,681	1,076	2,588	2,946	3,350	4,215
Prepaid Expenses	291.07	381.52	204.45	568.66	337.92	195
Other Current Assets	1,352	1,364	92.36	93.33	138.65	985
Total Current Assets	39,203	6,810	15,163	24,012	34,851	41,860
Property, Plant & Equipment	4,237	3,583	2,904	6,376	6,073	6,674
Long-Term Investments	23,072	22,732	1,593	1,469	4,930	4,875
Other Intangible Assets	52,170	33,170	31,170	33,175	33,664	39,395
Other Long-Term Assets	357.7	498.05	914.36	1,268	929.34	877.22
Total Assets	119,809	67,705	52,792	67,327	80,528	93,741
Accounts Payable	317.87	555.33	430.52	686.72	191.61	178.17
Accrued Expenses	135.31	137.19	141.71	141.35	123.66	143.59
Short-Term Debt	2,691	25,832	5,400	5,900	14,014	6,400
Current Portion of Long-Term Debt	-	-	-	111.08	833.32	833.36
Current Portion of Leases	463.54	440.49	114.1	196.17	354.1	369.82
Other Current Liabilities	1,071	521.41	860.43	1,957	1,744	1,652
Total Current Liabilities	4,678	27,487	6,947	8,992	17,261	9,577
Long-Term Debt	-	-	-	-	111.08	29,112
Long-Term Leases	218.98	320.53	32.43	41.7	174.69	423.22
Long-Term Deferred Tax Liabilities	-	-	-	-	1,296	2,073
Other Long-Term Liabilities	414.47	459.04	541.56	57.23	57.23	15
Total Liabilities	5,354	28,266	7,521	9,091	18,957	41,403
Common Stock	24,011	19,911	19,905	19,841	19,330	17,958
Additional Paid-In Capital	119,965	39,806	38,827	145,476	133,406	104,930
Retained Earnings	-29,964	-19,741	-12,812	-106,288	-90,481	-70,430
Treasury Stock	-4.04	-4.04	-4.04	-4.04	-4.04	-4.04
Comprehensive Income & Other	448.18	-532.99	-645.72	-789.52	-680.57	-116.86
Shareholders' Equity	114,455	39,438	45,271	58,235	61,571	52,338
Total Liabilities & Equity	119,809	67,705	52,792	67,327	80,528	93,741
Total Debt	3,373	26,593	5,547	6,249	15,488	37,138
Net Cash (Debt)	32,184	-22,937	6,265	12,483	6,712	-17,923
Net Cash Growth	-	-	-49.81%	86.00%	-	-
Net Cash Per Share	375.10	-288.02	78.76	158.55	90.90	-249.53
Filing Date Shares Outstanding	96.04	79.64	79.62	79.36	77.31	71.83
Total Common Shares Outstanding	96.04	79.64	79.62	79.36	77.31	71.83
Working Capital	34,525	-20,677	8,216	15,020	17,590	32,283
Book Value Per Share	1191.76	495.22	568.62	733.80	796.36	728.66
Tangible Book Value	62,285	6,269	14,101	25,061	27,906	12,943
Tangible Book Value Per Share	648.54	78.71	177.11	315.78	360.94	180.20
Land	1,100	1,100	1,100	1,100	1,100	1,100
Buildings	3,834	3,834	3,834	5,190	5,190	5,190
Machinery	10,435	10,435	10,435	11,644	13,822	13,822
Construction In Progress	-	980.27	16	773.4	225	-

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.